Stride
144.57
-0.23
-0.16%
LRN
10-10 16:10:00(美东时间)
高
148.37
开
144.55
量
45.48万股
总市值
63.07亿
低
143.98
换
1.04%
额
6603.44万
市盈TTM
21.90
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
游荡于人间
08-25 15:01
$Stride(LRN)$
这个几年前弄过,好像20多块的时候一买就涨的,然后有次财报后大跌了,我就卖了再没买过
哈哈不过我现在再看自己的烂操作不会很压抑了,吸收教训就好了,还是要放眼未来。
2赞
Stride(LRN)
08-15 05:35
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-021973 Size: 5 KB
网页链接
Stride(LRN)
08-15 05:35
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-021963 Size: 5 KB
网页链接
Stride(LRN)
08-20 04:25
$Stride(LRN)$
144 Report of proposed sale of securities Accession Number: 0001950047-25-006036 Act: 33 Size: 5 KB
网页链接
Stride(LRN)
07-31 21:25
$Stride(LRN)$
SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001644956-25-000040 Act: 34 Size: 6 KB
网页链接
Stride(LRN)
08-02 07:35
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020886 Size: 6 KB
网页链接
Stride(LRN)
08-02 07:35
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020888 Size: 6 KB
网页链接
Stride(LRN)
08-06 18:05
$Stride(LRN)$
10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-25-010334 Act: 34 Size: 14 MB
网页链接
Stride(LRN)
08-13 05:25
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-021507 Size: 7 KB
网页链接
Stride(LRN)
08-13 05:25
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-021505 Size: 9 KB
网页链接
chuminhua
09-12 10:50
9/11,默沙东(Merck & Co.)周四在欧洲临床微生物学与感染病学会(ESCMID)大会上公布了其21价肺炎链球菌结合疫苗Capvaxive的相关数据,这些数据表明,该疫苗——旨在预防成人侵袭性肺炎链球菌病和肺炎——也可能对高风险儿童有益。
这些新数据紧随该疫苗在欧盟针对18岁及以上人群获批之...
Stride(LRN)
08-13 05:15
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-021503 Size: 9 KB
网页链接
Stride(LRN)
09-25 05:35
$Stride(LRN)$
3 Initial statement of beneficial ownership of securities Accession Number: 0001207632-25-000004 Size: 9 KB
网页链接
Stride(LRN)
08-21 05:15
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022486 Size: 5 KB
网页链接
Stride(LRN)
08-21 05:25
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022489 Size: 5 KB
网页链接
Stride(LRN)
09-20 06:45
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-091766 Size: 10 KB
网页链接
Stride(LRN)
09-20 06:45
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-091767 Size: 10 KB
网页链接
Stride(LRN)
08-21 05:25
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-022493 Size: 7 KB
网页链接
港安健康
08-04 15:32
长久以来,无法切除的肝细胞癌(HCC)预后较差,使用索拉非尼等传统疗法的5年生存率通常低于10%。免疫治疗的问世极大地改变了这一现状。港安健康国际医疗介绍,HIMALAYA研究(NCT03298451)的延长随访结果表明,在不可切除肝细胞癌患者中,STRIDE(单次Tremelimumab[Imjudo],定期间隔Durvalumab[Imfin...
Stride(LRN)
07-30 05:05
$Stride(LRN)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-020468 Size: 5 KB
网页链接